000 01546 a2200409 4500
005 20250512043446.0
264 0 _c19881020
008 198810s 0 0 eng d
022 _a0304-3940
024 7 _a10.1016/0304-3940(88)90214-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReinhard, J F
245 0 0 _aPotentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
_h[electronic resource]
260 _bNeuroscience letters
_cAug 1988
300 _a349-53 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
650 0 4 _aAnimals
650 0 4 _aCatecholamines
_xmetabolism
650 0 4 _aCorpus Striatum
_xdrug effects
650 0 4 _aCytoplasmic Granules
_xdrug effects
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aDrug Interactions
650 0 4 _aHippocampus
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNorepinephrine
_xmetabolism
650 0 4 _aPyridines
_xmetabolism
650 0 4 _aReserpine
_xpharmacology
650 0 4 _aSubcellular Fractions
650 0 4 _aTetrabenazine
_xpharmacology
700 1 _aDaniels, A J
700 1 _aViveros, O H
773 0 _tNeuroscience letters
_gvol. 90
_gno. 3
_gp. 349-53
856 4 0 _uhttps://doi.org/10.1016/0304-3940(88)90214-5
_zAvailable from publisher's website
999 _c3267975
_d3267975